Dr Mark Belsky was notified that he was designated an “Experienced Injector” of Xiaflex for Dupuytren’s Disease (contracture). While Dr Belsky treats more than 300 people a year with Dupuytren’s Disease he continues to inject more than 50 people a year with Xiaflex. Along with his partner Dr. Matthew Leibman, Dr Belsky participated in the initial national study in 2008 demonstrating the benefits and safety of Xiaflex. All the members of Hand Surgery pc continue to successfully treat Dupuytren’s contractures with a variety of methods individualized to each patient.
Dr Mark Belsky designated “Experienced Injector” by Auxilium
posted in: Boston Sports Teams, Dr. Belsky